Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Monopar Therapeutics Inc. - Common Stock
(NQ:
MNPR
)
65.03
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Monopar Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Penny Stocks That Insiders Are Loading Up On: 3 Names to Watch Closely
↗
June 05, 2024
Penny stocks are risky. It’s why we attach a warning to the tail-end of penny stock articles and why the SEC has a warning about them too.
Via
InvestorPlace
Topics
Regulatory Compliance
Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
↗
June 03, 2024
Via
Benzinga
Monopar Announces CFO Succession
May 24, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 09, 2024
Via
Benzinga
MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q1 2024
↗
May 09, 2024
MNPR stock results show that Monopar Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Recap: Monopar Therapeutics Q4 Earnings
↗
March 28, 2024
Via
Benzinga
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
May 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 03, 2024
Via
Benzinga
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
April 18, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
April 16, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
April 10, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q4 2023
↗
March 28, 2024
MNPR stock results show that Monopar Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
March 28, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
March 05, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
March 19, 2024
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.
Via
Benzinga
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
February 27, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
February 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
February 23, 2024
Via
Benzinga
Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher
↗
February 23, 2024
U.S. stocks traded mostly higher midway through trading, with the Dow Jones index jumping more than 100 points on Friday. The Dow traded up 0.36% to 39,209.32 while the NASDAQ rose 0.01% to 16,042.80....
Via
Benzinga
Topics
Stocks
Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings
↗
February 23, 2024
U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.
Via
Benzinga
Topics
Stocks
Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results
↗
February 22, 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 400 points on Thursday. The Dow traded up 1.13% to 39,048.47 while the NASDAQ rose 2.93% to 16,037.52....
Via
Benzinga
Topics
Stocks
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
February 22, 2024
Shares of Etsy, Inc.
Via
Benzinga
What's Going On With Cancer-Focused Monopar Therapeutics Stock Today?
↗
February 22, 2024
Monopar Therapeutics soars 36% in premarket trading on robust volume. Exciting preclinical data reveals MNPR-101's potent anti-tumor efficacy in targeting uPAR-expressing cancers.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
February 22, 2024
Via
Benzinga
Crude Oil Rises 1%; US Jobless Claims Fall To 201,000
↗
February 22, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Thursday. The Dow traded up 0.67% to 38,872.01 while the NASDAQ rose 2.36% to 15,949.22. The S&P...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
February 22, 2024
Via
Benzinga
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
February 22, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
February 20, 2024
Via
Benzinga
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
↗
February 20, 2024
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The...
Via
Benzinga
Topics
Stocks
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
